Safety Violations at McDonald's, Yum China Supplier Company-Led: Regulator
Food safety violations at Shanghai Husi Food Co Ltd, a supplier to global brands including McDonald's Corp and Yum Brands Inc, were company-led and not the acts of individuals, the official Xinhua news agency said, citing the Shanghai food and drug watchdog.
McDonald's and KFC's parent Yum, along with a number of other global brands, have been pulled into a food safety scandal in China after it emerged that Shanghai Husi Food, a unit of US-based OSI Group LLC, had supplied expired meat to clients.
"We discovered that some of the company's illegal behavior was not the behavior of individuals, but rather an organized arrangement by the company," said the Shanghai Municipal Food and Drug Administration's deputy head, Gu Zhenhua, according to a Xinhua report late on Tuesday.
OSI has said it was "appalled" and was investigating the matter after a TV report showed staff at its Shanghai facility using expired meat and picking up meat from the floor to add to the mix.
An official at OSI in China reached by telephone on Wednesday declined to comment. In a separate statement, the Shanghai watchdog said it had sealed more than a thousand tonnes of suspected meat products from OSI in China, and a further 100 tonnes of products from a range of its clients.
The scandal has already spread to McDonald's operations in Japan, where a fifth of its Chicken McNuggets were sourced from Shanghai Husi Food, as well as dragging in coffee chain Starbucks, Burger King Worldwide Inc, Chinese fast food chain Dicos and a range of others.
McDonald's and Yum apologized to Chinese consumers on Monday, while a range of firms have said they will take any products sourced from Shanghai Husi Food off their shelves.
Copyright : Thomson Reuters 2014
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.